Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACE Study: Single-dose FE 106483 in Children with Nocturnal Enuresis
2005-002531-27Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Feb 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nocturnal enuresis (NE) comparing FE 106483 tablet single-dose with Placebo tablet single-dose (2 arms). Primary endpoint: Duration of action based on urinary osmolality. Started Feb 2006; status: completed.
02
Drugs
FE 106483
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on 2005-002531-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002531-27.